LXEO
LXEO
NASDAQ · Biotechnology

Lexeo Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$4.93
-0.05 (-1.00%)
As of Jun 21, 10:20 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +842.6% upside
Low Target $27.16
Average Target $46.47
High Target $57.70
Current Price $4.93
Current
$4.93
Target
$46.47
$27.16 $46.47 avg $57.70
Scenario Analysis
Bear Case
$27.16
450.9%
Low target
Base Case
$46.47
+842.6%
Avg target
Bull Case
$57.70
+1,070.4%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$10.99
-55.1% from high
52-Week Low
$3.60
+36.9% from low
Target vs 52W High
$46.47
+322.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%